Targeting HER2, BRAF, KRAS, MET, TRK

In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Evan W. Alley discusses the targeting of HER2, BRAF, KRAS, MET, and TRK mutations.<br /><br />Earn CME Credit for a related act... Author: imedex Added: 07/11/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | HER2